QJM Advance Access originally published online on May 15, 2007
QJM 2007 100(6):345-350; doi:10.1093/qjmed/hcm031
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes
From the 1Division of Community Health Sciences, University of Dundee, and 2Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
Address correspondence to Ms L.A. Donnelly, Division of Community Health Sciences, Mackenzie Building, Kirsty Semple Way, Dundee DD2 4BF. email: l.y.donnelly{at}dundee.ac.uk
Received 24 May 2005 and in revised form 25 January 2007
| Abstract |
|---|
Background: Good glycaemic control improves outcomes in patients with type 2 diabetes, but the extent to which this depends on adherence to insulin treatment is uncertain.
Aim: To investigate the association between adherence to insulin and glycaemic control in insulin-treated patients with type 2 diabetes.
Design: Observational records-based study.
Methods: We studied all patients with type 2 diabetes who were resident in Tayside, Scotland from 1 January 1995 to 30 September 2001, and who were treated with insulin. Adherence to insulin treatment was measured as the annual number of days of insulin coverage on the recommended dose, calculated from the amount of drug dispensed at community pharmacies and the recommended dose level for each patient. The association between glycaemic control (HbA1c), and adherence was determined, as was the influence of covariates, including age, sex, duration of diabetes and number of injections per day.
Results: A total of 1099 people were studied: 574 (52%) males and 525 (48%) females, mean ± SD age 62 ± 12 years, diabetes duration 10 ± 7 years. Median time in the study (time for which insulin was dispensed) was 1107 (range 3662446) days. Insulin prescribed was 58.0 ± 33.3 IU/day and insulin collected from pharmacies was 53.6 ± 27.1 IU/day. Mean adherence to insulin was thus 70.6%±17.7%. Adherence to insulin (p = 0.0021), BMI (p = 0.0001) and diabetes duration (p = 0.0314) were all significant predictors of HbA1c.
Discussion: Adherence to insulin appears poor in these type 2 diabetes patients, and there was a significant relationship between adherence and long-term metabolic control.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Meece Effect of insulin pen devices on the management of diabetes mellitus Am. J. Health Syst. Pharm., June 1, 2008; 65(11): 1076 - 1082. [Full Text] [PDF] |
||||
